Treatment of COVID-19 by Controlling the Activity of the Nuclear Factor-Kappa B
Open Access
- 1 January 2020
- journal article
- research article
- Published by Scientific Research Publishing, Inc. in CellBio
- Vol. 09 (02), 109-121
- https://doi.org/10.4236/cellbio.2020.92006
Abstract
Heavy infection of the virus leads to overproduction of cytokines. The overproduction of cytokine (cytokines storms) is responsible for the critical cases and deaths of COVID-19. The nuclear factor kappa-B stimulates the expression of the genes, which is responsible for cytokines storm and RNA transcription. The COVID-19 virus can be controlled by inhibition of nuclear factor kappa-B. Nuclear factor kappa-B is controlled by inhibition of hydrogen peroxide and inhibitor kappa-B kinase enzyme.Keywords
This publication has 25 references indexed in Scilit:
- Effect of Nrf2 activators on release of glutathione, cysteinylglycine and homocysteine by human U373 astroglial cellsRedox Biology, 2013
- Human GTPases Associate with RNA Polymerase II To Mediate Its Nuclear ImportMolecular and Cellular Biology, 2011
- The Intracellular Sensor NLRP3 Mediates Key Innate and Healing Responses to Influenza A Virus via the Regulation of Caspase-1Immunity, 2009
- The NLRP3 Inflammasome Mediates In Vivo Innate Immunity to Influenza A Virus through Recognition of Viral RNAImmunity, 2009
- Dynein Light Chain LC8 Negatively Regulates NF-κB through the Redox-dependent Interaction with IκBαOnline Journal of Public Health Informatics, 2008
- Chloroquine induces activation of nuclear factor‐κB and subsequent expression of pro‐inflammatory cytokines by human astroglial cellsJournal of Neurochemistry, 2003
- Toward Mechanism‐based Antioxidant InterventionsAnnals of the New York Academy of Sciences, 2002
- Sulfasalazine: a potent and specific inhibitor of nuclear factor kappa B.JCI Insight, 1998
- RNA POLYMERASE IIAnnual Review of Biochemistry, 1991
- Virology: CoronavirusesNature, 1968